Adventist Health System / Sunbelt Inc.
Orlando, FL Doing business as Adventhealth Orlando Part of Adventist Health System Sunbelt Healthcare Corporation
- UEI
- K3YFW6S3YQ67
- CAGE
- 338T3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Corporate family
-
-
Adventist Health System Sunbelt Healthcare Corporation
Parent
DASAFLTJUTD6
- Adventist Health System / Sunbelt Inc. K3YFW6S3YQ67
-
Adventist Health System Sunbelt Healthcare Corporation
Parent
DASAFLTJUTD6
- SAM.gov registration date
- Physical address
- 601 E Rollins St, Orlando, FL 32803, USA
- Website
- adventhealth.com
- Founded
- 1973
- Employees
- 50K-100K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Adventist Health System / Sunbelt Inc.
Adventist Health System / Sunbelt Inc., doing business as Adventhealth Orlando, is a tax-exempt non-profit hospital and child entity of Adventist Health System Sunbelt Healthcare Corporation, headquartered in Altamonte Springs, Florida. The organization acts as a federal research grant recipient (56% of recent awards as prime recipient) and sub-recipient (44% of recent awards), conducting clinical research in metabolic disease, diabetes, aging, oncology, and behavioral health through partnerships with the National Institutes of Health and other federal agencies.
Adventhealth Orlando's federal grant footprint centers on NIH-funded clinical research and translational studies. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is the largest funding partner, with 29 awards spanning metabolic and endocrine research. The National Institute on Aging funds 25 awards focused on exercise physiology, cognitive decline, and aging-related interventions. Representative prime grant work includes a $7.43 million cooperative agreement from NIDDK (CFDA 93.847) for ketone monitoring to mitigate diabetic ketoacidosis risk in Type 1 Diabetes patients on SGLT2 inhibitors, with University of Maryland, Baltimore as a named sub-awardee; a $176,256 National Cancer Institute project grant (CFDA 93.398) investigating dietary interventions and chemotherapy-induced peripheral neuropathy across the NCI-sponsored ENICTO Consortium; a $248,322 NIDDK project grant (CFDA 93.847) determining cell-level transcriptional aberrations in skeletal muscle insulin resistance using single-cell sequencing; and a $1 million community project funding award from the Healthcare Systems Bureau for pediatric ambulatory surgical center equipment at AdventHealth for Children. The organization also operates as a sub-recipient on approximately 48 federally funded studies led by research centers including University of Florida, University of Pennsylvania, Northwestern University, Pennsylvania State University, University of Pittsburgh, and Ball State University, focusing on diabetes phenotyping, exercise physiology, heart failure biomarkers, and muscle aging research.
Activity has accelerated sharply: six awards in 2022 to twenty-four in 2024, with recent deceleration to eight in 2026 through August. Twelve awards face completion within the next twenty-four months, representing recompete opportunity for competitive research sites. The Department of Justice Bureau of Prisons Southeast Regional Office and Federal Correctional Complex Coleman hold nine awards with $100 thousand combined potential value, separate from the NIH clinical research portfolio. Adventhealth Orlando's research infrastructure includes the Translational Research Institute (TRI), which houses metabolic testing capabilities (hyperinsulinemic euglycemic clamps, metabolic chambers, indirect calorimetry, muscle and adipose tissue biopsy protocols) and serves as a clinical trial site for multi-site NIH consortium studies. Combined potential value across all 109 awards (prime and sub, 2004–2026) is $621 thousand; however, actual obligated federal funding totals $106.9 million, indicating substantial underspending against potential ceilings and reflecting the nature of grant awards with rolling disbursement schedules.
Quick answers
What is Adventist Health System / Sunbelt Inc.'s UEI?
Adventist Health System / Sunbelt Inc.'s Unique Entity ID (UEI) in SAM.gov is K3YFW6S3YQ67.
What is Adventist Health System / Sunbelt Inc.'s CAGE code?
Adventist Health System / Sunbelt Inc.'s CAGE code is 338T3.
Where is Adventist Health System / Sunbelt Inc. located?
Adventist Health System / Sunbelt Inc.'s physical address in SAM.gov is 601 E Rollins St, Orlando, FL 32803, USA.
Is Adventist Health System / Sunbelt Inc. registered in SAM.gov?
Yes. Adventist Health System / Sunbelt Inc.'s SAM.gov registration is active through June 25, 2027.
Who is Adventist Health System / Sunbelt Inc.'s parent company?
Adventist Health System / Sunbelt Inc. is part of Adventist Health System Sunbelt Healthcare Corporation.
What is Adventist Health System / Sunbelt Inc.'s most recent federal award?
Adventist Health System / Sunbelt Inc.'s most recent federal grant award is Glucagon like peptide-1 medicine outcomes in real world patients with type 1 diabetes - project summary/abstract… (R03DK145927), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 1, 2026.
On GovTribe
See Adventist Health System / Sunbelt Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors